Haleon’s New UEFA Medical Deal Puts Voltaren in Football Spotlight—But Shares Lag
Haleon PLC is now the first Health Partner for UEFA Medical, landing the maker of Sensodyne and Voltaren a new foothold in football medicine. The move comes as Haleon looks to spotlight its over-the-counter pain brands in a consumer health sector that's turning more challenging. The company and UEFA have signed a multi-year deal aimed at advancing evidence-based pain management—think topical treatments, digital training modules, and webinars designed for medical staff. Topical NSAIDs, a class of painkillers applied directly to skin, not taken orally, are part of the focus.